Evogene Ltd. (EVGN)

NASDAQ: EVGN · IEX Real-Time Price · USD
0.659
-0.001 (-0.09%)
At close: Jun 14, 2024, 3:59 PM
0.692
+0.033 (5.00%)
After-hours: Jun 14, 2024, 4:20 PM EDT
-0.09%
Market Cap 33.36M
Revenue (ttm) 9.19M
Net Income (ttm) -21.47M
Shares Out 50.58M
EPS (ttm) -0.46
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 53,746
Open 0.651
Previous Close 0.660
Day's Range 0.640 - 0.669
52-Week Range 0.450 - 1.440
Beta 1.09
Analysts Strong Buy
Price Target 3.62 (+448.98%)
Earnings Date May 23, 2024

About EVGN

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, su... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 142
Stock Exchange NASDAQ
Ticker Symbol EVGN
Full Company Profile

Financial Performance

In 2023, Evogene's revenue was $5.64 million, an increase of 236.72% compared to the previous year's $1.68 million. Losses were -$23.88 million, -10.36% less than in 2022.

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for EVGN stock is "Strong Buy." The 12-month stock price forecast is $3.62, which is an increase of 448.98% from the latest price.

Price Target
$3.62
(448.98% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma

Preliminary Phase 1 results show promising trends for BMC128 in combination with nivolumab in refractory cancer patients. Data will be showcased at the 2024 American Society of Clinical Oncology (ASCO...

22 days ago - PRNewsWire

Evogene Reports First Quarter 2024 Financial Results

Conference call and webcast: today, May 23, 2024, 9:00 am ET Financial and Business Highlights: Q1 2024 revenue: $4.2M vs. $0.6M in Q1 2023; anticipating continued growth in 2024.

22 days ago - PRNewsWire

Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds

These agreements are expected to support the production of approximately 500 tons of additional seeds, enabling the completion of standing orders by the end of 2024 and positioning Casterra to fulfill...

24 days ago - PRNewsWire

Evogene Schedules First Quarter 2024 Financial Results Release

Zoom conference call scheduled for 9:00 AM ET REHOVOT, Israel , May 9, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize...

5 weeks ago - PRNewsWire

Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting

Preliminary data from Biomica's Phase 1 study of BMC128 will be showcased at the conference REHOVOT, Israel , April 16, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company de...

2 months ago - PRNewsWire

Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting

REHOVOT, Israel , April 11, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd.

2 months ago - PRNewsWire

Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry

Finally Foods is financed by the Israeli Innovation Authority (IIA) and The Kitchen Hub, and will be granted a license to utilize Evogene's AI technology REHOVOT, Israel , April 2, 2024 /PRNewswire/ -...

2 months ago - PRNewsWire

Evogene Announces Filing of Annual Report on Form 20-F

REHOVOT, Israel , March 28, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science-based product discovery and d...

2 months ago - PRNewsWire

Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification

REHOVOT, Israel , March 20, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) (the "Company", "Evogene"), a leading computational biology company targeting to revolutionize life-science pro...

3 months ago - PRNewsWire

Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing

REHOVOT, Israel , March 19, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and bio-pesticide novel products an...

3 months ago - PRNewsWire

Lavie Bio and Ceres Global Ag Corp. Collaborate to Include YalosTM Bio-Inoculant, in Regenerative Agriculture Initiatives in North America

REHOVOT, Israel , March 13, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and bio-pesticide novel products an...

3 months ago - PRNewsWire

Evogene Reports Fourth Quarter and Full Year 2023 Financial Results

Conference call and webcast: today, March 7, 2024, 9:00 am E.T. +1-888-407-2553 or +972-3- 9180608 I https://veidan.activetrail.biz/evogeneq4-2023 REHOVOT, Israel , March 7, 2024 /PRNewswire/ -- Evoge...

3 months ago - PRNewsWire

AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides

REHOVOT, Israel , March 6, 2024 /PRNewswire/ -- AgPlenus Ltd., a global leader in designing and developing novel sustainable crop protection products and a subsidiary of Evogene Ltd.

Other symbols: CTVA
3 months ago - PRNewsWire

Casterra Announces New Agreements with Seed Producers in Brazil and Africa to Meet Growing Demand for its Elite Castor Seed Varieties

The new agreements are expected to support additional production of approximately 400 tons of Casterra's elite castor seeds in 2024 and establish long-term production infrastructure REHOVOT, Israel , ...

3 months ago - PRNewsWire

Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements

The payment completes the $5M advance payment received under the licensing agreement for bio-fungicide product candidates REHOVOT, Israel , Feb. 28, 2024 /PRNewswire/ -- Lavie Bio Ltd., a leading ag-b...

Other symbols: CTVA
3 months ago - PRNewsWire

Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024

Conference call scheduled for 9:00 AM ET REHOVOT, Israel , Feb. 26, 2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize li...

3 months ago - PRNewsWire

AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer

REHOVOT, Israel , Feb. 22, 2024 /PRNewswire/ -- AgPlenus Ltd, a global leader in designing and developing novel sustainable crop protection products, and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (T...

4 months ago - PRNewsWire

AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution

The collaboration will tap into the potential of artificial intelligence (AI) to design and optimize crop protection chemistry, developing a novel sustainable Mode-of-Action (MoA) broad-spectrum herbi...

4 months ago - PRNewsWire

Syngenta and Lavie Bio Announce Partnership to Discover and Develop Novel Bio-Insecticide

Agreement reinforces both companies' commitment to developing and bringing innovative biological solutions to farmers BASEL, Switzerland and REHOVOT, Israel , Feb. 20, 2024 /PRNewswire/ -- Syngenta Cr...

4 months ago - PRNewsWire

Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation

The parties will identify and design probiotic bacteria that produce highly sustainable quantities of microbial metabolites, known to improve human health and vitality BOSTON and REHOVOT, Israel , Feb...

4 months ago - PRNewsWire

Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit

REHOVOT, Israel , Jan. 23, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd.

5 months ago - PRNewsWire

Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug

The final patient completes Phase I trial enrollment, evaluating safety and tolerability for Biomica's microbiome-based immuno-oncology drug, BMC128 REHOVOT, Israel , Jan. 17, 2024 /PRNewswire/ -- Bio...

5 months ago - PRNewsWire

Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024

REHOVOT, Israel , Dec. 21, 2023 /PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd.

6 months ago - PRNewsWire

Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation

Mr. Yoash Zohar, a seasoned ag executive, is joining Casterra as CEO to lead the company's significant operational expansion REHOVOT, Israel , Dec. 19, 2023 /PRNewswire/ -- Casterra Ag Ltd., a subsidi...

6 months ago - PRNewsWire

Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™

The agreement supports  Lavie Bio's 2024 sales growth plan for spring wheat, durum, and barley in Canada REHOVOT, Israel , Dec. 5, 2023 /PRNewswire/ -- Lavie Bio Ltd., a subsidiary of Evogene Ltd.

6 months ago - PRNewsWire